Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
P. Tanwar
Observed name:
Preety Tanwar
Institution:
All India Institute of Medical Sciences
Observed institutions:
DR. B.R.A. Institute Rotary Cancer Hospital,
All India Institute of Medical Sciences, Vijaypur, Jammu,
All India Institute of Medical Sciences
ORCID:
0000-0002-2357-976X
Observed ORCIDs:
0000-0002-2357-976X,
0009-0003-6861-9344
OpenAlex ID:
A5016280563
A phase II, randomized, open-label study to evaluate low-dose pembrolizumab plus chemotherapy versus chemotherapy as neoadjuvant therapy for localized triple-negative breast cancer (TNBC) (PLANeT trial—Pembrolizumab Low dose in Addition to NACT in TNBC)
2025
·
A. Arora
, H. Bhaskarane
, et al.
·
Annals of Oncology
·
20
Cooking fuel use and respiratory health of women and children in rural Ballabgarh, Haryana
2024
·
Preety Tanwar
, Rakesh Kumar
, et al.
·
International Archives of Occupational and Environmental Health
·
4
Comprehensive mutation profiling of PIK3CA gene in Indian breast cancer patients
2022
·
R. Kumar
, U. Agrawal
, et al.
·
European Journal of Cancer
·
1
181P Clinical insights and treatment outcomes of SDH deficient gastrointestinal stromal tumors (GIST): A retrospective analysis from a tertiary care center in India
2026
·
A. Naik
, S. Rastogi
, et al.
·
ESMO rare cancers.
107P Identification of novel targets in residual triple-negative breast cancer post-neoadjuvant chemoimmunotherapy to personalise adjuvant treatment
2025
·
A. Batra
, A. Kumar
, et al.
·
ESMO Open
PDF
EP11.01-011 Clinical Application of Liquid Biopsy for Assessing Early EGFR Mutation Detection in Non-Small Cell Lung Carcinoma
2022
·
A. Rathor
, P.S. Malik
, et al.
·
Journal of Thoracic Oncology
PDF
Show more works
View as search
Works count:
6
Citation count:
25
H-index:
2
I10-index:
1
Year
Topic
Type